CTRI/2018/02/011761已完成未知
Effect of zoledronate in hepatic osteodystrophy: a double blinded placebo controlled trial
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- JIPMER
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Lumbar spine Z score less than or equal to -2
排除标准
- •1. Child C cirrhosis
- •2. Chronic Kidney disease
- •3.. Current steroid use
- •4. Primary Hyperparathyroidism
- •5. Cushing Syndrome
- •6. Malignancies (Except Hepatocellular Carcinoma)
- •7. HIV infection
- •8. Current vertebral fractures
研究者
相似试验
尚未招募
不适用
Efficacy and Safety of Oral Ibandronate in Patients of Liver Cirrhosis With Hepatic Osteodystrophy.Hepatic OsteodystrophyLiver CirrhosisNCT06022237Institute of Liver and Biliary Sciences, India80
已完成
4 期
Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver DiseaseNonalcoholic Fatty LiverOsteoporosis, PostmenopausalNCT05493761Aristotle University Of Thessaloniki72
尚未招募
3 期
Effect of Saroglitazar in Non alcoholic fatty liver diseaseCTRI/2024/03/063735o sponsor
进行中（未招募）
1 期
Impact of Doravirine in Liver Steatosis and Fibrosis in PLWH. A pilot, proof of concept study (DORALI Study)Human Immunodeficiency VirusCTIS2023-504952-87-00Fundacion Fls De Lucha Contra El Sida Las Enfermedades Infecciosas Y La Promocion De La Salud Y La Ciencia50
招募中
3 期
Study of Orphenadrine' in the Treatment of Muscle Cramps in Patients With CirrhosisLiver CirrhosisMuscle CrampsNCT02423395Sherief Abd-Elsalam100